1. Home
  2. CLLS vs CTGO Comparison

CLLS vs CTGO Comparison

Compare CLLS & CTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • CTGO
  • Stock Information
  • Founded
  • CLLS 1999
  • CTGO 2009
  • Country
  • CLLS France
  • CTGO United States
  • Employees
  • CLLS N/A
  • CTGO N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • CTGO Precious Metals
  • Sector
  • CLLS Health Care
  • CTGO Basic Materials
  • Exchange
  • CLLS Nasdaq
  • CTGO Nasdaq
  • Market Cap
  • CLLS 240.2M
  • CTGO 255.7M
  • IPO Year
  • CLLS 2007
  • CTGO N/A
  • Fundamental
  • Price
  • CLLS $1.57
  • CTGO $10.54
  • Analyst Decision
  • CLLS Buy
  • CTGO Strong Buy
  • Analyst Count
  • CLLS 3
  • CTGO 1
  • Target Price
  • CLLS $7.00
  • CTGO $37.00
  • AVG Volume (30 Days)
  • CLLS 59.8K
  • CTGO 174.5K
  • Earning Date
  • CLLS 11-04-2024
  • CTGO 02-12-2025
  • Dividend Yield
  • CLLS N/A
  • CTGO N/A
  • EPS Growth
  • CLLS N/A
  • CTGO N/A
  • EPS
  • CLLS N/A
  • CTGO N/A
  • Revenue
  • CLLS $36,042,000.00
  • CTGO N/A
  • Revenue This Year
  • CLLS $271.02
  • CTGO N/A
  • Revenue Next Year
  • CLLS $33.48
  • CTGO $122.34
  • P/E Ratio
  • CLLS N/A
  • CTGO N/A
  • Revenue Growth
  • CLLS 46.96
  • CTGO N/A
  • 52 Week Low
  • CLLS $1.53
  • CTGO $10.10
  • 52 Week High
  • CLLS $3.55
  • CTGO $25.32
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 27.91
  • CTGO 23.96
  • Support Level
  • CLLS $1.85
  • CTGO $11.36
  • Resistance Level
  • CLLS $2.09
  • CTGO $12.06
  • Average True Range (ATR)
  • CLLS 0.09
  • CTGO 0.84
  • MACD
  • CLLS -0.04
  • CTGO -0.03
  • Stochastic Oscillator
  • CLLS 0.00
  • CTGO 12.83

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's primary focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Tetlin Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska.

Share on Social Networks: